High-dose chemotherapy for triple negative breast cancer

Ann Oncol. 2007 Jan;18(1):202-203. doi: 10.1093/annonc/mdl306. Epub 2006 Sep 13.

Authors

U De Giorgi¹, G Rosti², L Frassineti³, B Kopf², N Giovannini³, F Zumaglini², M Marangolo²

Affiliations

¹ Istituto Oncologico Romagnolo, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, Ravenna. Electronic address: ugo_degiorgi@yahoo.com.
² Istituto Oncologico Romagnolo, Department of Oncology and Hematology, Santa Maria delle Croci Hospital, Ravenna.
³ Istituto Oncologico Romagnolo, Department of Oncology, Pierantoni Hospital, Forli, Italy.

PMID: 16971660
DOI: 10.1093/annonc/mdl306

No abstract available

Publication types

Clinical Trial, Phase II
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / metabolism
Breast Neoplasms / pathology
Dose-Response Relationship, Drug
Feasibility Studies
Female
Humans
Middle Aged
Receptor, ErbB-2 / metabolism*
Receptors, Estrogen / metabolism*
Receptors, Progesterone / metabolism*

Substances

Receptors, Estrogen
Receptors, Progesterone
Receptor, ErbB-2